189 related articles for article (PubMed ID: 25843691)
1. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
[TBL] [Abstract][Full Text] [Related]
4. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.
Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y
Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
7. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
[TBL] [Abstract][Full Text] [Related]
12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
14. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
16. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
Avoranta ST; Korkeila EA; Ristamäki RH; Syrjänen KJ; Carpén OM; Pyrhönen SO; Sundström JT
Hum Pathol; 2013 Jun; 44(6):966-74. PubMed ID: 23332924
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
Fischer AK; Pham DL; Bösmüller H; Lengerke C; Wagner P; Bachmann C; Beschorner C; Perner S; Kommoss S; Fend F; Staebler A
Virchows Arch; 2019 Oct; 475(4):479-488. PubMed ID: 31451895
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Pan H; Wu N; Huang Y; Li Q; Liu C; Liang M; Zhou W; Liu X; Wang S
Diagn Pathol; 2015 Jun; 10():66. PubMed ID: 26070788
[TBL] [Abstract][Full Text] [Related]
19. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]